Results: 1-25 | 26-27
Results: 1-25/27

Authors: Flood, L Lofberg, R Stierna, P Wikstrom, AC
Citation: L. Flood et al., Glucocorticoid receptor mRNA in patients with ulcerative colitis: A study of responders and nonresponders to glucocorticoid steroid therapy, INFLAMM B D, 7(3), 2001, pp. 202-209

Authors: Blomqvist, P Feltelius, N Lofberg, R Ekbom, A
Citation: P. Blomqvist et al., A 10-year survey of inflammatory bowel diseases - drug therapy, costs and adverse reactions, ALIM PHARM, 15(4), 2001, pp. 475-481

Authors: Schreiber, S Campieri, M Colombel, JF van Deventer, SJH Feagan, B Fedorak, R Forbes, A Gassull, M Gendre, JP van Hogezand, RA Lofberg, R Modigliani, R Pallone, F Petritsch, W Prantera, C Rampton, D Seibold, F Vatn, M Zeitz, M Rutgeerts, P
Citation: S. Schreiber et al., Use of anti-tumour necrosis factor agents in inflammatory bowel disease - European guidelines for 2001-2003, INT J COL R, 16(1), 2001, pp. 1-11

Authors: Askling, J Dickman, PW Karlen, P Brostrom, O Lapidus, A Lofberg, R Ekbom, A
Citation: J. Askling et al., Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study, LANCET, 357(9252), 2001, pp. 262-266

Authors: Gonzalez-Lara, V Lofberg, R Armengol, JAR Fazio, V Irvine, EJ Garcia-Paredes, J
Citation: V. Gonzalez-lara et al., The long-term evolution of ulcerative colitis, DRUGS TODAY, 37, 2001, pp. 89-90

Authors: Lofberg, R
Citation: R. Lofberg, Cancer risk in inflammatory bowel diseases, DRUGS TODAY, 37, 2001, pp. 95-99

Authors: Blanco, PR Pena, AS Moser, G Millan, JMP Heijnen, CJ Pecasse, L Lofberg, R
Citation: Pr. Blanco et al., Psychosomatic aspects, quality of life, emotional stress, neuroendocrine mediators and the role of patients' associations in the treatment of inflammatory bowel disease, DRUGS TODAY, 37, 2001, pp. 191-192

Authors: Geboes, K Riddell, R Ost, A Jensfelt, B Persson, T Lofberg, R
Citation: K. Geboes et al., Grading system for inflammation in ulcerative colitis - Reply, GUT, 48(5), 2001, pp. 737-737

Authors: Askling, J Dickman, PW Karlen, P Brostrom, O Lapidus, A Lofberg, R Ekbom, A
Citation: J. Askling et al., Family history as a risk factor for colorectal cancer in inflammatory bowel disease, GASTROENTY, 120(6), 2001, pp. 1356-1362

Authors: Jarnerot, G Strom, M Danielsson, A Kilander, A Loof, L Hultcrantz, R Lofberg, R Floren, CH Nilsson, A Brostrom, O
Citation: G. Jarnerot et al., Allopurinol in addition to 5-aminosalicyclic acid based drugs for the maintenance treatment of ulcerative colitis, ALIM PHARM, 14(9), 2000, pp. 1159-1162

Authors: Campieri, M Cohen, Z Griffiths, A Ejderhamm, J Lofberg, R Rutgeerts, P Sachar, D Tremaine, W Vatn, M
Citation: M. Campieri et al., Session II and III panel discussion, DRUGS TODAY, 36, 2000, pp. 93-101

Authors: Lofberg, R Cohen, Z Cortot, A Ejderhamm, J Gomollon, F Graffner, H Griffiths, A Lobo, A Rutgeerts, P Sachar, D Stange, E Tremaine, W Vatn, M
Citation: R. Lofberg et al., Case presentation: Extensive colorectal Crohn's disease, DRUGS TODAY, 36, 2000, pp. 121-128

Authors: Stange, E Cohen, Z Gomollon, F Lobo, A Lofberg, R Pena, AS Rutgeerts, P Sachar, D Tremaine, W
Citation: E. Stange et al., Case presentation: Steroid refractory colitis, DRUGS TODAY, 36, 2000, pp. 129-133

Authors: Tremaine, W Lofberg, R Rutgeerts, P Sachar, D Stange, E
Citation: W. Tremaine et al., Case presentation: Crohn's disease with perianal involvement, DRUGS TODAY, 36, 2000, pp. 141-145

Authors: Cohen, Z Lofberg, R Rutgeerts, P
Citation: Z. Cohen et al., Case presentation: Rectal remnant complications, DRUGS TODAY, 36, 2000, pp. 147-151

Authors: Geboes, K Riddell, R Ost, A Jensfelt, B Persson, T Lofberg, R
Citation: K. Geboes et al., A reproducible grading scale for histological assessment of inflammation in ulcerative colitis, GUT, 47(3), 2000, pp. 404-409

Authors: Elzouki, AN Eriksson, S Lofberg, R Nassberger, L Wieslander, J Lindgren, S
Citation: An. Elzouki et al., The prevalence and clinical significance of alpha(1)-antitrypsin deficiency (PiZ) and ANCA specificities (Proteinase 3, BPI) in patients with ulcerative colitis, INFLAMM B D, 5(4), 1999, pp. 246-252

Authors: Stahlberg, D Lofberg, R
Citation: D. Stahlberg et R. Lofberg, Underlying cholangiocarcinoma in a patient with high-grade dysplasia in the pelvic pouch - Comment, INFLAMM B D, 5(2), 1999, pp. 150-151

Authors: Torkvist, L Thorlacius, H Sjoqvist, U Bohman, L Lapidus, A Flood, L Agren, B Raud, J Lofberg, R
Citation: L. Torkvist et al., Low molecular weight heparin as adjuvant therapy in active ulcerative colitis, ALIM PHARM, 13(10), 1999, pp. 1323-1328

Authors: Sjoqvist, U Ost, A Lofberg, R
Citation: U. Sjoqvist et al., Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis, INT J COL R, 14(2), 1999, pp. 107-113

Authors: Lofberg, R
Citation: R. Lofberg, Is potent topical steroids the solution in collagenous colitis?, INT J COL R, 14(1), 1999, pp. 62-62

Authors: Lofberg, R
Citation: R. Lofberg, Treatment of fistulas in Crohn's disease with infliximab, GUT, 45(5), 1999, pp. 642-643

Authors: Hellers, G Cortot, A Jewell, D Leijonmarck, CE Lofberg, R Malchow, H Nilsson, LG Pallone, F Pena, S Persson, T Prantera, C Rutgeerts, P
Citation: G. Hellers et al., Oral budesonide for prevention of postsurgical recurrence in Crohn's disease, GASTROENTY, 116(2), 1999, pp. 294-300

Authors: Rawsthorne, P Shanahan, F Cronin, NC Anton, PA Lofberg, R Bohman, L Bernstein, CN
Citation: P. Rawsthorne et al., An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease, AM J GASTRO, 94(5), 1999, pp. 1298-1303

Authors: Karlen, P Lofberg, R Brostrom, O Leijonmarck, CE Hellers, G Persson, PG
Citation: P. Karlen et al., Increased risk of cancer in ulcerative colitis: A population-based cohort study, AM J GASTRO, 94(4), 1999, pp. 1047-1052
Risultati: 1-25 | 26-27